Clayton Dehn

Metabolic Disorders Steering Committee Member at Foundation for the National Institutes of Health

Clayton Dehn currently serves as Chief Scientific Officer and Therapeutic Area Lead for Metabolism & Endocrinology at Evolution Research Group since 2021. Simultaneously, Clayton is a member of the Metabolic Disorders Steering Committee and the NIMBLE Leadership Team at the Foundation for the National Institutes of Health, contributing to advancements in non-invasive biomarkers for managing liver diseases. Previous roles include Vice President of Clinical Pharmacology Services at High Point Clinical Trials Center, Senior Vice President at Clinical Trials of Texas, Co-Founder and CEO of Umbrella Corporation, and Executive Director at Celerion. Clayton began academic pursuits at the University of Jamestown, working towards a PhD in Clinical Research, following a Master’s degree in Physiology from Texas Tech University.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


F

Foundation for the National Institutes of Health

2 followers

Medical science is poised like never before to crack the code to some of humankind’s most vexing health challenges


Employees

51-200

Links